- Soumettre
- Personnaliser
- Aide
- de
- en
- fr
- it
- visiteur :: identification
Cohort Profile: Antiretroviral Therapy Cohort Collaboration (ART-CC)
May, Margaret T. ; Ingle, Suzanne M. ; Costagliola, Dominique ; Justice, Amy C. ; de Wolf, Frank ; Cavassini, Matthias ; D'Arminio Monforte, Antonella ; Casabona, Jordi ; Hogg, Robert S. ; Mocroft, Amanda ; Lampe, Fiona C. ; Dabis, François ; Fätkenheuer, Gerd ; Sterling, Timothy R. ; del Amo, Julia ; Gill, M John ; Crane, Heidi M. ; Saag, Michael S. ; Guest, Jodie ; Brodt, Hans-Reinhard ; Sterne, Jonathan AC
In: International Journal of Epidemiology, 2014, vol. 43, no. 3, p. 691-702
Ajouter à la liste personnelleVoir aussi
Liens
Exporter vers
- Titre
-
- Cohort Profile: Antiretroviral Therapy Cohort Collaboration (ART-CC)
- Auteur
-
- May, Margaret T.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Ingle, Suzanne M.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Costagliola, Dominique. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Justice, Amy C.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- de Wolf, Frank. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Cavassini, Matthias. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- D'Arminio Monforte, Antonella. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Casabona, Jordi. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Hogg, Robert S.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Mocroft, Amanda. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Lampe, Fiona C.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Dabis, François. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Fätkenheuer, Gerd. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Sterling, Timothy R.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- del Amo, Julia. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Gill, M John. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Crane, Heidi M.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Saag, Michael S.. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Guest, Jodie. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Brodt, Hans-Reinhard. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Sterne, Jonathan AC. School of Social and Community Medicine, University of Bristol, Bristol, UK, 2UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, 3Yale University School of Medicine, New Haven, CT, USA, 4VA Connecticut Healthcare System, West Haven, CT, USA, 5Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, 6University Hospital Lausanne, Lausanne, Switzerland, 7Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, 8Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, 9Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 10Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, 11Research Department of Infection and Population Health, UCL Medical School, London, UK, 12INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, 13Department of Internal Medicine University of Cologne, DE, 14Vanderbilt University School of Medicine, Nashville, TN, USA, 15National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, 16Division of Infectious Diseases, University of Calgary, Calgary, Canada, 17University of Washington School of Medicine, Seattle, WA, USA, 18Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, 19HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and 20Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany
- Type de document
-
- Postprint
- Langue
-
- Anglais
- Publié dans
-
- International Journal of Epidemiology, 2014, vol. 43, no. 3, p. 691-702. Oxford University Press
- Autre version électronique
-
- Publisher's version : https://doi.org/10.1093/ije/dyt010
- Classification
-
- Santé
- Mots clés
- Identifiant OAI-PMH
-
- oai:doc.rero.ch:302038
- Summary
- The advent of effective combination antiretroviral therapy (ART) in 1996 resulted in fewer patients experiencing clinical events, so that some prognostic analyses of individual cohort studies of human immunodeficiency virus-infected individuals had low statistical power. Because of this, the Antiretroviral Therapy Cohort Collaboration (ART-CC) of HIV cohort studies in Europe and North America was established in 2000, with the aim of studying the prognosis for clinical events in acquired immune deficiency syndrome (AIDS) and the mortality of adult patients treated for HIV-1 infection. In 2002, the ART-CC collected data on more than 12,000 patients in 13 cohorts who had begun combination ART between 1995 and 2001. Subsequent updates took place in 2004, 2006, 2008, and 2010. The ART-CC data base now includes data on more than 70 000 patients participating in 19 cohorts who began treatment before the end of 2009. Data are collected on patient demographics (e.g. sex, age, assumed transmission group, race/ethnicity, geographical origin), HIV biomarkers (e.g. CD4 cell count, plasma viral load of HIV-1), ART regimen, dates and types of AIDS events, and dates and causes of death. In recent years, additional data on co-infections such as hepatitis C; risk factors such as smoking, alcohol and drug use; non-HIV biomarkers such as haemoglobin and liver enzymes; and adherence to ART have been collected whenever available. The data remain the property of the contributing cohorts, whose representatives manage the ART-CC via the steering committee of the Collaboration. External collaboration is welcomed. Details of contacts are given on the ART-CC website (www.art-cohort-collaboration.org)